Cell and Gene at the Abbey
Production, Scale-up and Global Harmonisation
Conference Agenda
DAY 01: 10TH NOVEMBER 2021 | |||
---|---|---|---|
TIME | SPEAKER | COMPANY | TITLE OF TALK |
09.00 | Aoife Duffy / Brian Harrison | HiTech Health | Introduction and Update on HTH Cell & Gene Therapy Programme |
09.15 | Prof. Francesco Curcio | University of Udine | Clinical use of MSCs: the experience at the University of Udine Medical Centre. |
10.00 | Scott Olsen | University of Texas | Developing Potency Measures of MSC and MSC-like Products. |
10.45 | COFFEE | ||
11.15 | Shirley O'Dea | Avectas | Solupore Non-viral Cell Engineering Platform. |
12.00 | Brian O’ Connor | Meira GTx | Challenges in Viral Vector Manufacture & Processes. |
12.45 | LUNCH | ||
14.00 | Qasim Rafiq | UCL | Automated Process Development and Manufacturing Strategies for ATMPs. |
14.45 | Mandana Haack-Sørensen | Rigshospitalet | Automation of cell therapy manufacturing: Lessons learned on compliance, product quality and production consistency. |
15.30 | COFFEE | ||
16.00 | Benjamin Gysi / Áine Adams | Takeda Pharmaceutical | Update on Takeda´s Cell Therapy Strategy Development. |
18.00 | Drinks Reception | ||
19.30 | Dinner @ Glenlo Sponsored by AccuScience | ||
DAY 02: 11TH NOVEMBER 2021 | |||
TIME | SPEAKER | COMPANY | TITLE OF TALK |
09.00 | Bruce Levine | UPenn | Development, Regulatory Approval, and Improvements in Engineered T Cell Therapies. |
09.45 | Massimo Dominici | University Hospital of Modena and Reggio Emilia Modena, Italy | Scaling up anti-cancer gene therapies: challenges and opportunities. |
10.30 | COFFEE | ||
11.00 | Prof. Garry Duffy | NUIG | Ambient Cell Transport and Implant Delivery Using Device and Biomaterial Approach. |
11.45 | Bernd Kullman | Sigilon Therapeutics | ATMP Manufacturing, Release, and Distribution: establishing a supply network and reducing risk for a time and temperature sensitive product. |
12.30 | LUNCH | ||
13.45 | Róisín O'Cearbhaill | Memorial Sloan Kettering | Overcoming challenges of cellular therapies in solid tumours. |
14.30 | Knut Niss | MustangBio | From MSCs to CARTs: How Manufacturing of ATMPs changed over the Last Decade. |
15.15 | COFFEE | ||
15.30 | Workshop | ||
18.30 | Dinner in The Galmont Sponsored by Meira GTx. | ||
DAY 03: 12TH NOVEMBER 2021 | |||
TIME | SPEAKER | COMPANY | TITLE OF TALK |
09.00 | Niamh Curran | HPRA | ATMPs- a regulatory update and lessons learned so far. |
09.45 | Nisha Durand | Mayo Clinic | Insights into the Operations of a small cGMP Cell Therapy Manufacturing Facility in an Academic Setting. |
10.30 | Patrick Hanley | Children’s National Hospital, The George | Overcoming Challenges in the Cellular Therapy Laboratory. |
11.15 | COFFEE | ||
11.45 | Michael O’Dwyer | ONK Therapeutics | Fundraising as a CGT start up: The agony and the ecstasy! |
12.30 | Jim Faulkner / Michael O’Dwyer | Venture Partner / ONK Therapeutics | Investing in Advanced Therapies. |
13.15 | LUNCH |
Fee & Cancellation Policy
Rate includes 2.5 days conference attendance with workshop on Day 2, coffees, lunches, a drinks reception and 2 dinners.
Early Bird Registration, before April 30th, 2021
[SALES ENDED]
€1,250 per attendee
2 or more from one company €1,000 per attendee
General Registration, after May 01st, 2021
[NOW AVAILABLE]
€1,500 per attendee
2 or more from one company €1,250 per attendee
Academic rate available upon request.
Cancellation possible until September 30th subject to a €100.00 cancellation fee.
Registration
Accommodation
Accommodation is available at the Glenlo Abbey Hotel, and can be booked directly via the hotel or via e-mail at reservation@glenloabbey.ie using promo-code ‘HiTechHealth’. Special rate of €160 B&B single or €170 for Twin or Double.
In addition, rooms are also available at the Harbour Hotel (www.harbour.ie) located in Galway City. Bookings can be made directly via the hotel or via e-mail at reservations@harbour.ie using promo-code ‘HiTechHealth’. Special rate of €129 B&B single or €139 for Twin or Double. Transfer will be organised for attendees staying in this hotel to the venue each morning of the meeting.
Contact
T: +353 1 963 1489
T: +353 1 960 2100
E: info@hitech-health.com
HiTech Health Authorised by the MHRA to Perform Batch Importation and Certification of Investigational Medicinal Products (IMPs)
HiTech Health today announced that the company has been granted a Manufacturer’s/Importation Authorisation (MIA) for Investigational Medicinal Products (IMP) by the Medicines and Healthcare Products Regulatory Agency (MHRA). The company is now authorised to perform...
Cell Therapy: Points to Consider When Choosing a CDMO
At the Advanced Therapies Congress 2024 in London, Amina Al-Mossawi, a Qualified Person (QP) at Hitech Health, delivered vital insights on the crucial considerations for biotech firms when selecting a Contract Development and Manufacturing Organisation (CDMO). With...
Accelerating Regenerative Medicine : CCRM Australia and HiTech Health Announce Strategic Partnership
Hitech Health is delighted to announce its latest partnership with CCRM Australia, a not-for-profit organisation supporting regenerative medicine commercialisation in the Australian market. CCRM Australia works to accelerate the commercialisation of regenerative...
Telephone
IE: +353-1-9631489
UK: +44-20-30267419
US: +1-857-3265835
Contact us
Get in touch anytime – we are always available to discuss your upcoming projects.